IGF1R and diabetes mellitus: Prevention of diabetes and treatments targeting abnormal glucose metabolism, IGF-1/IGF-1R signaling axis, and insulin resistance may provide novel opportunities to improve prognosis and delay the lethal metastases of intraocular malignancies.